Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending July 19, 2020 Cabozantinib holds promise for bone metastases in HR-positive breast cancer, Tamoxifen offers survival benefit in male breast cancer, Second primary breast cancer risk has increased in men and women, Mastectomy: Continuous wound infiltration with ropivacaine reduces postop pain, Outdoor nighttime light exposure may be a risk factor for postmenopausal breast cancer, More must reads Must reads for theWeek ending July 12, 2020 AGA releases BRCA risk guidance, Heavy menstrual bleeding difficult to control in young patients with inherited platelet disorders, Children rarely transmit SARS-CoV-2 within households, Transitioning regimen may prolong proteasome inhibitor–based therapy for MM, Interim PET/CT identifies poor-risk DLBCL patients after R-CHOP14, More must readsMust reads for theWeek ending July 5, 2020 Chewed prasugrel for primary PCI? Forget it!, Real-world data support adjuvant immunotherapy for stage III melanoma, Novel SERD, LSZ102, shows promise for pretreated ER+ breast cancer, Tiragolumab plus atezolizumab active in PD-L1+ NSCLC, Lipid-lowering drugs appear to decrease colorectal cancer death across subgroups, More must readsMust reads for theWeek ending June 28, 2020 Combo drug improves survival in older patients with high-risk/secondary AML, Venetoclax plus LDAC tops LDAC alone in AML, Tumor markers are ‘valuable’ for relapse detection in rare CNS tumors, Personalized cancer vaccine may enhance checkpoint inhibitor activity, Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AML, More must readsMust reads for theWeek ending June 21, 2020 Minority-serving hospitals had similar survival after liver cancer surgery, First-in-kind anti-CD47 antibody shows promise for MDS and AML treatment, New registry focuses on rheumatic immune-related AEs of cancer therapy, VIALE-A confirms survival benefit for venetoclax-azacitidine in hard-to-treat AML, Vulvar melanoma is increasing in older women, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 last »